Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma

NCT02278315

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Jacksonville, Florida, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
View Trial Details
Completed

A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma

NCT05007652

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • The Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
  • Hospital of the University of Occupational and Environmental Health Kitakyushu, Fukuoka, Japan
  • Hokkaido University Hospital of the National University Corporation Sapporo, Hokkaido, Japan
View all 21 locations
View Trial Details
Completed

Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy

NCT02609828

Conditions
Blood Protein Disorders, Bone Metastasis, Cancer Pain, +18 more
Locations
  • Instituto de Oncologia de Rosario Rosario, Santa Fe Province, Argentina
  • Monash Medical Centre Clayton, Victoria, Australia
  • Monash Medical Centre East Bentleigh, Victoria, Australia
  • Landesklinikum Krems Krems, Austria
View all 89 locations
View Trial Details

Related conditions